Azlocillin, A Potential New Drug for Persistent Lyme Disease

Azlocillin, a New Drug to Treat Lyme Disease

Is it possible that there may finally be a drug that might successfully treat Chronic Lyme Disease?

Jayakumar Rajadas, assistant professor of medicine and director of the Biomaterials and Advanced Drug Delivery Laboratory at the Stanford University School of Medicine says, “It [Azlocillin] clears the infection [Borrelia Burgdorferi]  without a lot of side effects.”

The new findings suggest the drug azlocillin not only kills off the Borrelia burgdorferi bacteria during the initial acute stages of illness, but could also be effective for treating patients with persistent symptoms of Lyme disease.

Futurity reports that researchers, Pothineni and Rajadas have patented the compound for the treatment of Lyme disease and are working with a company to develop an oral form of the drug. Researchers plan to conduct a clinical trial.


Disulfiram, a New Hope for Lyme Disease Treatment

Whatis lyme logo

One thought on “Azlocillin, A Potential New Drug for Persistent Lyme Disease”

  1. This is NOT a new drug, it just stopped being manufactured. Allen Steere and company knew all about this in the mid 80’s and I’m sure if someone chose to dig, they’re probably behind its demise, because it worked. It wasnt part of the master moneymaking grand scheme of things. Or whatever they’ve been up to for 35+ years.

Leave a Reply

Your email address will not be published.